These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38180590)

  • 41. Real-World Experience With Antiplatelet Agents After Percutaneous Coronary Intervention in Patients With an Indication for an Oral Anticoagulant.
    Tanner R; Cronin M; Macken L; Murphy R; Maree AO; Ullah I; Cosgrave J; O'Connor S; Daly C
    J Cardiovasc Pharmacol; 2021 Apr; 77(4):501-507. PubMed ID: 33818553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study.
    Ahn HJ; Lee SR; Choi J; Lee KY; Kwon S; Choi EK; Oh S; Lip GYH
    Europace; 2024 Feb; 26(2):. PubMed ID: 38290433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Initial Experience With High-Risk Patients Excluded From Clinical Trials: Safety of Short-Term Anticoagulation After Left Atrial Appendage Closure Device.
    Barakat AF; Hussein AA; Saliba WI; Bassiouny M; Tarakji K; Kanj M; Jaber W; Rodriguez LL; Grimm R; Hussain MS; Russman A; Uchino K; Wisco D; Rasmussen P; Bain M; Vargo J; Zuccaro G; Gottesman D; Lindsay BD; Wazni OM
    Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27225288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct current cardioversion practices following percutaneous left atrial appendage closure.
    Bhuta S; Shaaban A; Binda NC; Antaki J; Augostini RS; Kalbfleisch SJ; Savona SJ; Okabe T; Houmsse M; Afzal MR; Daoud EG; Hummel JD
    J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1698-1705. PubMed ID: 37493499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
    Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
    BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion.
    Della Rocca DG; Magnocavallo M; Di Biase L; Mohanty S; Trivedi C; Tarantino N; Gianni C; Lavalle C; Van Niekerk CJ; Romero J; Briceño DF; Bassiouny M; Al-Ahmad A; Burkhardt JD; Natale VN; Gallinghouse GJ; Del Prete A; Forleo GB; Sanchez J; Lakkireddy D; Horton RP; Gibson DN; Natale A
    JACC Cardiovasc Interv; 2021 Nov; 14(21):2353-2364. PubMed ID: 34656496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of Left Atrial Appendage Closure and Oral Anticoagulation After Atrial Fibrillation Catheter Ablation.
    Fei ZT; Yao PC; Qiu JH; Chen M; Fei YD; Li W; Zhang PP; Sun J; Wang QS; Li YG
    Am J Cardiol; 2023 Oct; 204():312-319. PubMed ID: 37567023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meta-analysis of postoperative antithrombotic therapy after left atrial appendage occlusion.
    Li SY; Wang J; Hui X; Zhu HJ; Wang BY; Xu H
    J Int Med Res; 2020 Nov; 48(11):300060520966478. PubMed ID: 33249962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Direct oral anticoagulant plus antiplatelet therapy: prescribing practices and bleeding outcomes.
    Tinkham TT; Vazquez SR; Jones AE; Witt DM
    J Thromb Thrombolysis; 2020 Apr; 49(3):492-496. PubMed ID: 31776847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticoagulation With or Without Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement for Patients With Atrial Fibrillation: A Meta-Analysis.
    Yokoyama Y; Briasoulis A; Takagi H; Kuno T
    Cardiovasc Revasc Med; 2021 Mar; 24():42-47. PubMed ID: 32830088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of gender in patients with device-related thrombosis after left atrial appendage closure - A sub-analysis from the multicenter EUROC-DRT-registry.
    Saw J; Vij V; Galea R; Piayda K; Nelles D; Vogt L; Gloekler S; Fürholz M; Meier B; Räber L; O'Hara G; Arzamendi D; Agudelo V; Asmarats L; Freixa X; Flores-Umanzor E; De Backer O; Sondergaard L; Nombela-Franco L; Salinas P; Korsholm K; Nielsen-Kudsk JE; Zeus T; Operhalski F; Schmidt B; Montalescot G; Guedeney P; Iriart X; Miton N; Gilhofer T; Fauchier L; Veliqi E; Meincke F; Petri N; Nordbeck P; Gonzalez-Ferreiro R; Cruz-González I; Bhatt DL; Laricchia A; Mangieri A; Omran H; Schrickel JW; Beiert T; Rodes-Cabau J; Nickenig G; Sievert H; Sedaghat A; Afzal S
    Echocardiography; 2024 Aug; 41(8):e15888. PubMed ID: 39042643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials.
    Bing S; Chen RR
    Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study.
    Antúnez-Muiños P; López-Tejero S; Cepas-Guillén P; Mon-Noboa M; Ruiz-Nodar JM; Andrés-Lalaguna L; Rivero F; Córdoba-Soriano JG; Amat-Santos IJ; Caneiro-Queija B; Sánchez DM; Sánchez JJ; Mezcua FT; Blanco-Fernández F; Sánchez JS; Moreno-Ambroj C; Estévez-Loureiro R; Nombela-Franco L; Freixa-Rofastes X; Cruz-González I
    EuroIntervention; 2024 Aug; 20(16):1018-1028. PubMed ID: 39155755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antithrombotic Regimen After Percutaneous Left Atrial Appendage Closure　- A Real-World Study.
    Ryuzaki S; Kondo Y; Nakano M; Nakano M; Kajiyama T; Ito R; Kitagawa M; Sugawara M; Chiba T; Yoshino Y; Kobayashi Y
    Circ J; 2023 Nov; 87(12):1820-1827. PubMed ID: 37344404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation.
    Kosmidou I; Liu Y; Alu MC; Liu M; Madhavan M; Chakravarty T; Makkar R; Thourani VH; Biviano A; Kodali S; Leon MB
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1580-1589. PubMed ID: 31439338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dual Antithrombotic Therapy versus Anticoagulant Monotherapy for Major Adverse Limb Events in Patients with Concomitant Lower Extremity Arterial Disease and Atrial Fibrillation: A Propensity Score Weighted Analysis.
    Lin DS; Wu HP; Chung WJ; Hsueh SK; Hsu PC; Lee JK; Chen CC; Huang HL
    Eur J Vasc Endovasc Surg; 2024 Oct; 68(4):498-507. PubMed ID: 38754724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.
    Smits PC; Frigoli E; Tijssen J; Jüni P; Vranckx P; Ozaki Y; Morice MC; Chevalier B; Onuma Y; Windecker S; Tonino PAL; Roffi M; Lesiak M; Mahfoud F; Bartunek J; Hildick-Smith D; Colombo A; Stankovic G; Iñiguez A; Schultz C; Kornowski R; Ong PJL; Alasnag M; Rodriguez AE; Moschovitis A; Laanmets P; Heg D; Valgimigli M;
    Circulation; 2021 Oct; 144(15):1196-1211. PubMed ID: 34455849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.